Clinical Trial Update: Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports safety, tolerability and preliminary efficacy of CYP-006TK in adults with diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Ulcer
• Diabetic Foot Ulcer

Drugs mentioned

• CYP-006TK

Snippet

Sponsor: Cynata Therapeutics Limited | Conditions: Diabetic Foot Ulcer, Cutaneous Ulcer | Phase 1 | Status: COMPLETED